Multiple sclerosis and risk of venous thromboembolism: A population-based cohort study

Neuroepidemiology

Volumn 38, Issue 2, 2012, Pages 76-83

  Christensen, Steffen ^a   Farkas, Dóra Körmendiné ^a   Pedersen, Lars ^a   Miret, Montserrat ^b   Christiansen, Christian Fynbo ^a   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b MERCK SERONO S A   (Switzerland)

Author keywords

Cohort study; Multiple sclerosis; Risk; Venous thromboembolism

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DENMARK; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION RESEARCH; REGISTER; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ADULT; AGED; COHORT STUDIES; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PULMONARY EMBOLISM; RISK; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84856153647     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000335496     Document Type: Article

References (30)

1. Poser CM, Brinar VV: The accuracy of prevalence rates of multiple sclerosis: A critical review. Neuroepidemiology 2007; 29: 150-155.
2. Myhr KM, Riise T, Vedeler C, Nortvedt MW, Gronning R, Midgard R, Nyland HI: Disability and prognosis in multiple sclerosis: Demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Scler 2001; 7: 59-65.
3. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M: Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
4. Heit JA: The epidemiology of venous thromboembolism in the community: Implications for prevention and management. J Thromb Thrombolysis 2006; 21: 23-29.
5. Sorensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P: Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: A 20-year cohort study. Lancet 2007; 370: 1773-1779.
6. Kaufman J, Khatri BO, Riendl P: Are patients with multiple sclerosis protected from thrombophlebitis and pulmonary embolism? Chest 1988; 94: 998-1001.
7. Koch-Henriksen N, Bronnum-Hansen H, Stenager E: Underlying cause of death in Danish patients with multiple sclerosis: Results from the Danish Multiple Sclerosis Registry. J Neurol Neurosurg Psychiatry 1998; 65: 56-59.
8. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH: The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-268.
9. Frank L: Epidemiology. When an entire country is a cohort. Science 2000; 287: 2398-2399.
10. Christiansen CF, Christensen S, Farkas DK, Miret M, Sorensen HT, Pedersen L: Risk of arterial cardiovascular diseases in patients with multiple sclerosis: A population-based cohort study. Neuroepidemiology 2010; 35: 267-274.
11. Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjonneland A, Johnsen SP: Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol 2010; 63: 223-228.
12. Glynn RJ, Rosner B: Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005; 162: 975-982.
13. Hosmer DW Jr., Lemeshow S: Applied Survival Analysis. Regression Modeling of Time-to-Event Data. Hoboken, NJ, Wiley, 2008.
14. Minagar A, Jy W, Jimenez JJ, Sheremata WA, Mauro LM, Mao WW, Horstman LL, Ahn YS: Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001; 56: 1319-1324.
15. Aksungar FB, Topkaya AE, Yildiz Z, Sahin S, Turk U: Coagulation status and biochemical and inflammatory markers in multiple sclerosis. J Clin Neurosci 2008; 15: 393-397.
16. Chapman J: Thrombin in inflammatory brain diseases. Autoimmun Rev 2006; 5: 528-531.
17. Ramsaransing GS, Fokkema MR, Teelken A, Arutjunyan AV, Koch M, De Keyser J: Plasma homocysteine levels in multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77: 189-192.
18. Sheremata WA, Jy W, Horstman LL, Ahn YS, Alexander JS, Minagar A: Evidence of platelet activation in multiple sclerosis. J Neuroinflammation 2008; 5: 27.
19. Huerta C, Johansson S, Wallander MA, Garcia Rodriguez LA: Risk factors and shortterm mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 2007; 167: 935-943.
20. Russell MW, Taylor DC, Cummins G, Huse DM: Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients. Am J Manag Care 2002; 8:S3-S9.
21. Kniffin WD Jr., Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr.: The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 861-866.
22. Schulman S, Lindmarker P: Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. N Engl J Med 2000; 342: 1953-1958.
23. Friend KB, Mernoff ST, Block P, Reeve G: Smoking rates and smoking cessation among individuals with multiple sclerosis. Disabil Rehabil 2006; 28: 1135-1141.
24. Hernan MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H: Cigarette smoking and the progression of multiple sclerosis. Brain 2005; 128: 1461-1465.
25. Nortvedt MW, Riise T, Maeland JG: Multiple sclerosis and lifestyle factors: The Hordaland Health Study. Neurol Sci 2005; 26: 334-339.
26. Slawta JN, Wilcox AR, McCubbin JA, Nalle DJ, Fox SD, Anderson G: Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis. Arch Phys Med Rehabil 2003; 84: 1823-1830.
27. Nielsen NM, Westergaard T, Frisch M, Rostgaard K, Wohlfahrt J, Koch-Henriksen N, Melbye M, Hjalgrim H: Type 1 diabetes and multiple sclerosis: A Danish populationbased cohort study. Arch Neurol 2006; 63: 1001-1004.
28. Sorensen HT: Regional administrative health registers as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with examples of use. Int J Risk Safety Med 1997; 10: 1-22.
29. Sorensen HT, Lash TL, Rothman KJ: Beyond randomized controlled trials: A critical comparison of trials with nonrandomized studies. Hepatology 2006; 44: 1075-1082.
30. The Danish Society of Thrombosis and Hemostasis: Venous thromboprophylaxis. Ugeskr Laeger 2000. Guidelines report No 3.